News

Lastest news

15 November 2023

Fundraising for animals! >

During the year, we support several organizations that deal with animals and do priority work.

30 October 2023

Award winning Ceva stand! >

We are happy to share the news that at the HVG job fair held between October 4-6, 2023, Ceva won the 1st prize for the most attractive stand in the 9-16 sqm category.

13 June 2023

New General Manager at the head of Ceva-Phylaxia >

As part of this transformation, with effect from 13.06.2023, Dr. Tamás Szamkó took over the position of General Manager of Ceva-Phlyaxia Zrt.

22 January 2019

Major new investment announced to develop 2nd vaccine production site in Hungary >

24 July 2017

Ceva continues to deliver double-digit growth >

Libourne 24th July 2017 - Consolidated sales of the Ceva Group reached €546m at the end of June 2017, representing growth of 20% versus last year and +6.6% at constant perimeter and exchange rates.

12 July 2017

Ceva Phylaxia inaugurates state of the art vaccine plant to support “Innovation with Impact” growth plan >

Budapest, Hungary, July : Ceva Santé Animale, one of the fastest growing, top 10 animal healthcare companies today held the inauguration ceremony of its new European vaccine production facility

20 February 2017

Ceva reinforces its position in china and swine through new joint-venture with EBVAC >

In the presence of the Chinese Prime Minister, Li Keqiang and French Prime Minister, Bernard Cazeneuve, Ceva Santé Animale (Ceva) and EBVAC today signed a joint-venture agreement to create a new business, Ceva EBVAC, focused on the swine sector.

8 February 2017

Ceva Santé Animale confirms its circle of virtuous growth in 2016 >

2016 was a year of sustained organic growth and major acquisitions. Consolidated sales reached €912m as the Ceva Group continued to achieve double-digit growth, cementing its position as the 6th. largest animal health company.

30 January 2017

Ceva stresses the need for continued innovation to ensure effective disease control at IPPE 2017 >

Vectormune® ND, vaccine for Newcastle Disease (ND) Cevac IBird®, for Infectious Bronchitis (IB) prevention will continue to lead offerings for effective and easily administered disease control.

29 January 2017

Launch of the WVPA-Ceva joint digital library >

Launch of a digital library resource on poultry veterinary medicine

Back to top